Tempus’ AI-based ECG-AF device receives FDA clearance
The ECG-AF device is developed to help identify patients at AF risk.
27 June 2024
27 June 2024
The ECG-AF device is developed to help identify patients at AF risk.
While oncology has been the primary focus, companion diagnostics are increasingly being developed for other therapeutic areas such as infectious diseases.
The LVIS EVO device is designed for treating wide-neck intracranial aneurysms.
The integration of advanced software in medical devices and the use of AI are setting new standards in neurological disease treatment.
Telehealth is increasingly viewed as a tool to alleviate staffing pressures in the US as its function as a standalone service falters.
Research by Incogni found that there have been 1,572 healthcare hacks since 2020.
The clinical trial will treat 25 patients who have experienced recurrent symptomatic pleural effusion with the ACES system.
The company’s deep brain stimulation device used in combination with medication is more effective in treating major depressive disorder compared to medication alone.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.